EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria

Cristina Carvalho, Paula I Moreira

Current Opinion in Neurobiology · 2023-04 · 79 · 102694

DOI: 10.1016/j.conb.2023.102694 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Neurobiology, 2023-04. Verfasst von Cristina Carvalho und 1 weiteren Autor:innen. Beteiligte Einrichtung: CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Center for Innovation in Biomedicine and Biotechnolo…. Hauptthemen laut MEDLINE: Alzheimer Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Programa Operacional Temático Factores de Competitividade, European Society for Clinical Investigation, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) and Alzheimer's disease (AD) are two global epidemics that share several metabolic defects, such as insulin resistance, impaired glucose metabolism, and mitochondrial defects. Importantly, strong evidence demonstrates that T2D significantly increases the risk of cognitive decline and dementia, particularly AD. Here, we provide an overview of the metabolic defects that characterize and link both pathologies putting the focus on mitochondria. The biomarker potential of mitochondrial components and the therapeutic potential of some drugs that target and modulate mitochondria are also briefly discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDiabetes Mellitus, Type 2HumansBiomarkersMitochondria

Stichwörter der Autor:innen

Alzheimer's diseasediabetesmetabolic disordersmitochondriamitochondrial biomarkers and therapies

Substanzen

Biomarkers

Autor:innen und Institutionen

  • CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Center for Innovation in Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; IIIUC - Institute for In…
  • CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Center for Innovation in Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; Institute of Physiology,…

Förderung

  • Programa Operacional Temático Factores de Competitividade
  • European Society for Clinical Investigation
  • Fundação para a Ciência e a Tecnologia
  • European Regional Development Fund

Zitieren

APA

Carvalho, C., & Moreira, P. I. (2023). Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria. Current Opinion in Neurobiology, 79, 102694. https://doi.org/10.1016/j.conb.2023.102694

Vancouver

Carvalho C, Moreira PI. Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria. Current Opinion in Neurobiology. 2023;79:102694. doi:10.1016/j.conb.2023.102694

BibTeX
@article{Carvalho2023,
  author = {Carvalho, Cristina and Moreira, Paula I},
  title = {Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria},
  journal = {Current Opinion in Neurobiology},
  year = {2023},
  volume = {79},
  pages = {102694},
  doi = {10.1016/j.conb.2023.102694}
}
Kostenlos starten →